SLC22A1 and type 2 diabetes mellitus: These findings lead to a recommendation of further studies involving more subjects for a safe approach of metformin dose, particularly in T2DM patients with the G allele SLC22A1 Met408del to prevent metformin accumulation beyond the recommended therapeutic range.